The latest total revenue for IH is $600M as of March 2026. That compares with $900M in the prior-year period — down 33.3% year over year. That is below the sector sector average of $1.4B. Investors often review this figure alongside iHuman's historical trend and sector peers before judging valuation or financial health.

Over the past year, IH's total revenue moved from $900M to $600M — a 33.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in iHuman's operating scale or balance-sheet position.

Against its sector companies, IH currently prints $600M for total revenue, while the sector average sits near $1.4B. That is roughly 57.0% below the sector mean. Large gaps often invite a closer look at iHuman's growth, margins, and balance sheet.

A total revenue figure of $600M for IH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $1.4B. Explore the charts below for those layers of context.

After noting IH's total revenue ($600M), review year-over-year change from $900M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.